4D Molecular Therapeutics, Inc.FDMTNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-2.91%
↑ 88% above average
Average (30q)
-24.55%
Historical baseline
Range
High:56.52%
Low:-244.78%
Volatility
-1227.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -2.91% |
| Q2 2025 | -10.88% |
| Q1 2025 | 4.45% |
| Q4 2024 | -9.75% |
| Q3 2024 | -20.44% |
| Q2 2024 | -11.33% |
| Q1 2024 | -4.05% |
| Q4 2023 | -162.29% |
| Q3 2023 | 56.52% |
| Q2 2023 | -6.74% |
| Q1 2023 | -4.83% |
| Q4 2022 | -8.40% |
| Q3 2022 | 6.79% |
| Q2 2022 | -7.71% |
| Q1 2022 | -6.57% |
| Q4 2021 | -9.28% |
| Q3 2021 | -198.33% |
| Q2 2021 | 53.43% |
| Q1 2021 | 20.13% |
| Q4 2020 | -161.28% |
| Q3 2020 | 48.41% |
| Q2 2020 | -14.10% |
| Q1 2020 | 18.49% |
| Q4 2019 | 4.32% |
| Q3 2019 | -95.07% |
| Q2 2019 | 0.00% |
| Q1 2019 | -244.78% |
| Q4 2018 | 0.00% |
| Q3 2018 | 5.15% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |